Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Provider profile

NovoCare Pharmacy — compounded GLP-1 pricing & profile

Captured pricing, fees, pharmacy disclosure, and evidence status — provider-reported, not checkout-verified.

NovoCare Pharmacy is a manufacturer / brand-access channel — a channel for FDA-approved products, profiled here for context but never ranked as a compounded provider. Compounded and approved products are different regulatory classes and are not compared on the same axis.

Provider-reported, not checkout-verified. This profile is built from captured public data and is not a scored, full editorial review. NovoCare Pharmacy is not assigned a score or a "verified cheapest" claim; figures are provided for transparency and comparison and should be confirmed with the provider.

Captured pricing

NovoCare Pharmacy does not publish a single flat compounded price in the captured data. Semaglutide: FDA-approved Wegovy pill: $149/month for 1.5 mg; $199 for 4 mg after limited offer; $299 for 9 mg and 25 mg. Wegovy pen: $199/month for first 2 eligible new-patient fills, then $349/month standard; W…. Tirzepatide: Not applicable. Because no stable per-plan figure was captured, NovoCare Pharmacy is shown for transparency but is not placed in the ranked pricing tables. Confirm current pricing on the provider's own page before relying on any figure.

Fees, pharmacy, and disclosure

NovoCare Pharmacy — captured structure and disclosures (2026-07-20)
CategoryManufacturer / brand-access channel
Current statusActive but evidence incomplete
Membership / program feeMedication price; pharmacy delivery/pickup pathway
Pharmacy disclosureNot verified
Material relationshipNo known material relationship — publisher attested 2026-07-20; independent verification not performed
Evidence statusPROVIDER REPORTED · confidence high
Last checked2026-07-20
Official sourceprovider page

Capture note: Limited-time offers have end dates; dose-specific standard price applies afterward.

How to read this channel

As a manufacturer or brand-access channel, NovoCare Pharmacy supplies FDA-approved product, which carries premarket-reviewed manufacturing that compounded products do not. If you have insurance coverage or qualify for a manufacturer cash-pay program, an approved product can be cheaper and better-evidenced than any compounded option — price that first. See the brand-vs-compounded cost guide. This channel is never ranked against compounded providers.

Frequently asked questions

How much does NovoCare Pharmacy charge for compounded GLP-1?

NovoCare Pharmacy did not publish a single flat compounded price in the captured data — fda-approved wegovy pill: $149/month for 1.5 mg; $199 for 4 mg after limited offer; $299 for 9 mg and 25 mg. wegovy pen: $199/month for first 2 eligible new-patient fills, then $349/month standard; w…. Confirm current pricing directly with the provider, and compute effective monthly cost at your maintenance dose before comparing.

Does NovoCare Pharmacy charge a membership fee?

As a brand-access channel, its fee structure differs from compounded telehealth. Captured: Medication price; pharmacy delivery/pickup pathway. A required membership belongs in the effective-cost math, so add it in before comparing NovoCare Pharmacy to any flat-priced provider.

Is NovoCare Pharmacy's pricing verified?

No. NovoCare Pharmacy's evidence status is provider reported (confidence high); figures are provider-reported or independently calculated, not checkout-verified, and its pharmacy disclosure is "not verified". Treat every figure as a starting point to confirm, not a guarantee.